Testing Health Workers At Risk to Advance Our Understanding of TB Infection
THWART-TB: Testing Health Workers At Risk to Advance Our Understanding of TB Infection
Beth Israel Deaconess Medical Center
300 participants
Jan 15, 2024
OBSERVATIONAL
Conditions
Summary
It has been estimated that 1.7 billion people have tuberculosis (TB) infection; yet current tests are unable to predict which people are at highest risk of developing TB disease, which can be life-threatening. THWART-TB is a prospective longitudinal cohort study of health workers (HWs) in Cape Town, South Africa, where our preliminary data reveals HWs have a high annual TB infection risk (34%). This cohort, who will undergo frequent serial evaluation (every 3 months) with a combination of novel assays never previously evaluated together, presents a unique opportunity to evaluate immune responses at the time of initial infection and to characterize the dynamic profile of these immune responses over time in a high-risk population. The knowledge generated will improve our understanding of TB infection and help to identify which people exposed to TB may remain at risk, enabling us to better target preventive strategies.
Eligibility
Inclusion Criteria3
- ≥18 years old
- Health worker
- Able to provide informed consent
Exclusion Criteria2
- Prior history of TB or known prior positive IGRA
- Current or prior history of taking anti-TB treatment
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Diagnostic testing with existing and novel tests to evaluate for TB infection and disease
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06221488